- Home
- IVP vs PLRZ Comparison
IVP vs PLRZ Comparison
Compare IVP & PLRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVP
- PLRZ
- Stock Information
- Founded
- IVP 2020
- PLRZ 2005
- Country
- IVP United States
- PLRZ Israel
- Employees
- IVP N/A
- PLRZ N/A
- Industry
- IVP Diversified Commercial Services
- PLRZ
- Sector
- IVP Miscellaneous
- PLRZ
- Exchange
- IVP Nasdaq
- PLRZ NYSE
- Market Cap
- IVP 3.3M
- PLRZ 3.7M
- IPO Year
- IVP 2023
- PLRZ 2024
- Fundamental
- Price
- IVP $0.97
- PLRZ $0.71
- Analyst Decision
- IVP
- PLRZ
- Analyst Count
- IVP 0
- PLRZ 0
- Target Price
- IVP N/A
- PLRZ N/A
- AVG Volume (30 Days)
- IVP 74.7K
- PLRZ 2.9M
- Earning Date
- IVP 08-13-2025
- PLRZ 02-15-2025
- Dividend Yield
- IVP N/A
- PLRZ N/A
- EPS Growth
- IVP N/A
- PLRZ N/A
- EPS
- IVP N/A
- PLRZ N/A
- Revenue
- IVP $15,399,751.00
- PLRZ N/A
- Revenue This Year
- IVP N/A
- PLRZ N/A
- Revenue Next Year
- IVP N/A
- PLRZ N/A
- P/E Ratio
- IVP N/A
- PLRZ N/A
- Revenue Growth
- IVP N/A
- PLRZ N/A
- 52 Week Low
- IVP $0.90
- PLRZ $0.55
- 52 Week High
- IVP $401.50
- PLRZ $1,200.00
- Technical
- Relative Strength Index (RSI)
- IVP 24.79
- PLRZ N/A
- Support Level
- IVP $1.58
- PLRZ N/A
- Resistance Level
- IVP $1.76
- PLRZ N/A
- Average True Range (ATR)
- IVP 0.14
- PLRZ 0.00
- MACD
- IVP -0.07
- PLRZ 0.00
- Stochastic Oscillator
- IVP 7.85
- PLRZ 0.00
About IVP Inspire Veterinary Partners Inc.
Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.